Pharmacotherapy for Autism Spectrum Disorder
The Carlat Child Psychiatry Report, Volume 12, Number 3&4, April 2021
Matthew Krause, DO
Child psychiatrist with Primary Health Network, Latrobe, PA
Dr. Krause has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
What’s new in psychopharmacological treatment for autism? We interviewed Dr. Matthew Krause on his recent review of seven studies covering the rationale for treatment, target symptoms, the use of antipsychotics, over the counter supplements, and some new ideas in pharmacotherapy for ASD.